M Hanefeld

27.6k citations
306 papers · 17.4k · 5 hit papers · h-index 63

Impact in

Papers in

M Hanefeld

292 papers receiving 16.4k citations

M Hanefeld's Hit Papers

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial 2009 · 1.0k citations
1.0k0+10+20Years since publication50010001.5k

Peers

M Hanefeld
Comparison fields: 5 of 159
  • Endocrinology, Diabetes and Metabolism 9.3k
  • Pharmacology 1.4k
  • Cardiology and Cardiovascular Medicine 1.7k
  • Physiology 1.9k
  • Biochemistry 515
Replace Ramón Gomis with:
Ramón Gomis Spain
Clifford J. Bailey United Kingdom
Riccardo C. Bonadonna Italy
Itamar Raz Israel
Eleuterio Ferrannini Italy
Cesare R. Sirtori Italy
John J. Albers United States
Jorge Plutzky United States
Robert R. Henry United States
H Bryan Brewer United States
M Hanefeld relative to Ramón Gomis Spain Ramón Gomis's profile →
Citations per field
00.5×2.8×
Ramón Gomis · 1×
Citations per year

Countries citing papers authored by M Hanefeld

Since Specialization
Citations

This map shows the geographic impact of M Hanefeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Hanefeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Hanefeld more than expected).

Fields of papers citing papers by M Hanefeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Hanefeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Hanefeld. The network helps show where M Hanefeld may publish in the future.

Co-authors

The 25 scholars most cited alongside M Hanefeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M Hanefeld Line = papers co-authored together M Hanefeld links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 306 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Hit paper breakdown →
20021809
2
Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance
Hit paper breakdown →
20031229
3
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Hit paper breakdown →
20091011
4
Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up
Hit paper breakdown →
1996706
5
Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis
Hit paper breakdown →
2007560
6 2006492
7 2003485
8 2000449
9 1995404
10 2011299
11 1999292
12 2004228
13 2004202
14 2016200
15 2003197
16 2004196
17 2004192
18 1999180
19 2008163
20 2010153

About M Hanefeld

M Hanefeld is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Cardiology and Cardiovascular Medicine, Epidemiology and Physiology, having authored 306 papers that have together received 17.4k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (68 papers), Diabetes Treatment and Management (63 papers), Diabetes Management and Research (45 papers), Metabolism, Diabetes, and Cancer (38 papers), Diet and metabolism studies (28 papers), Lipoproteins and Cardiovascular Health (23 papers), Adipokines, Inflammation, and Metabolic Diseases (22 papers) and Liver Disease Diagnosis and Treatment (16 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (9.3k citations), Pharmacology (1.4k citations), Cardiology and Cardiovascular Medicine (1.7k citations), Physiology (1.9k citations) and Biochemistry (515 citations). M Hanefeld has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Ramón Gomis, Markku Laakso, Jean‐Louis Chiasson, Avraham Karasik, Theodora Temelkova‐Kurktschiev, Robert G. Josse, Carsta Koehler, Elena Henkel, Henning Beck‐Nielsen and Nigel C. Jones. Their work appears in journals such as Diabetes Care, Experimental and Clinical Endocrinology & Diabetes, Diabetologia, Atherosclerosis and Hormone and Metabolic Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact